Hing C. Wong - Jul 19, 2021 Form 3 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Executive Officer, Director
Signature
/s/ Hing C. Wong
Stock symbol
HCWB
Transactions as of
Jul 19, 2021
Transactions value $
$0
Form type
3
Date filed
7/19/2021, 04:52 PM
Next filing
Jul 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HCWB Common Stock 4.29M Jul 19, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCWB Series A Redeemable Preferred Stock Jul 19, 2021 Common Stock 6.32M Direct F1, F2
holding HCWB Series B Redeemable Preferred Stock Jul 19, 2021 Common Stock 2.95M Direct F3, F4
holding HCWB Series C Redeemable Preferred Stock Jul 19, 2021 Common Stock 1.07M Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series A Redeemable Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.
F2 Includes 902,977 shares purchased jointly by Hing C. Wong and Bee Yau Huang.
F3 The Series B Redeemable Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.
F4 Includes 1,525,714 shares purchased jointly by Hing C. Wong and Bee Yau Huang.
F5 The Series C Redeemable Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.
F6 Represents shares purchased jointly by Hing C. Wong and Bee Yau Huang.

Remarks:

Exhibit 24.1: Power of Attorney